EC actions against the rising threats from Antimicrobial Resistance

Workshop on Antimicrobial Resistance

Koen Van Dyck Head of Unit

SANTE DDG2.G4: Food, Alert system and Training Directorate General Health & Food Safety (DG SANTE)

European Commission

16-17 November 2015 – Brussels

According to data from 2011, 25 000 patients die annually as a result of infections caused by resistant bacteria in the EU. The costs incurred by drug resistant infections amount to an estimated €1.5 billion annually, due to increases in healthcare expenditure costs and productivity losses.

http://www.compoundchem.com/2014/09/08/antibiotics/

AMR is a major European and global societal problem

Decision-makers Scientific advice

CHVPCVMPESVAC

Committees

Scientific committees

SCENIHR

EARS-NetESAC-Net

Networks

Regulations; Directives; EC communications /

decisions; Council conclusions / resolutions /

recommendations

Guidelines, technical reports, scientific advice,

recommendations

Guidelines, reports

Codex Alimentarius

International organisations

AMR a public health priority

Some actions taken so far:

Ban on the use of AM for growth promotion (2006)

Monitoring AMR and use of antimicrobials(EU agencies: EFSA, EMA, ECDC)

International activities (TATFAR, Codex, OIE)

Research

Scientific opinions, data on monitoring

Not enough, further action needed !

55

AMR a public health priority!

6

COM (2011) 748 – 17 Nov 2011• 5 year action plan• Holistic approach• 7 key areas• 12 concrete actions

1. Appropriate use

4. Prevention of infections

6. New antibiotics

9. Surveillance

The 12 actions

Human

2 & 3. Appropriate use

5. Prevention of infections

7. Need for new antibiotics

10. Surveillance

Veterinary

8. International cooperation

11. Research & Innovation

12. Communication, education

7

A. Appropriate use of antimicrobialsAction nº1: Strengthen the promotion of the appropriate use of antimicrobials in human medicine in all Member States

Action nº2: Strengthen the regulatory framework on veterinary medicines and on medicated feed

Action nº3: Introduce recommendations for prudent use in veterinary medicine

B. Prevent microbial infections & spread

Action nº4: Strengthen infection prevention and control in healthcare settings

Action nº5: Adoption of a proposal for an EU Animal Health Law

C. Develop new effective AM or alternatives for treatment

Action nº6: Promote unprecedented collaborative research

Action nº7: Promote efforts to analyse need for new antibiotics into veterinary medicine

D. Join forces with international partners

Action nº8: Develop and / or strengthen multilateral and bilateral commitments for the prevention and control of AMR

E. Monitoring and surveillanceAction nº9: Strengthen surveillance systems on AMR and antimicrobial consumption in human medicine

Action nº10: Strengthen surveillance systems on AMR and antimicrobial consumption in animal medicine

F. Additional Research and InnovationAction nº11: Reinforce and co-ordinate research efforts. Innovation.

G. Communication, education and training

Action nº12: Survey and comparative effectiveness research

Next steps

• Dedicated webpage http://ec.europa.eu/dgs/health_food-safety/amr/index_en.htm

• AMR progress report http://ec.europa.eu/health/antimicrobial_resistance/docs/2015_amr_progress_report_en.pdf

• AMR Roadmap http://ec.europa.eu/health/antimicrobial_resistance/docs/roadmap_amr_en.pdf

• Ex-post evaluation (February 2016)

Concluding remarks

• AMR remain a top priority for European Commission to lead at EU and work at global level

• Ongoing evaluation of the EC Action Plan – basis to decide on the follow-up

• Importance of concrete actions and implementation of the action plans by all stakeholders and Member States.

Thank you for your attention